1. Home
  2. OSPN vs STOK Comparison

OSPN vs STOK Comparison

Compare OSPN & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OSPN
  • STOK
  • Stock Information
  • Founded
  • OSPN 1991
  • STOK 2014
  • Country
  • OSPN United States
  • STOK United States
  • Employees
  • OSPN N/A
  • STOK N/A
  • Industry
  • OSPN EDP Services
  • STOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • OSPN Technology
  • STOK Health Care
  • Exchange
  • OSPN Nasdaq
  • STOK Nasdaq
  • Market Cap
  • OSPN 633.9M
  • STOK 517.0M
  • IPO Year
  • OSPN 1998
  • STOK 2019
  • Fundamental
  • Price
  • OSPN $15.30
  • STOK $11.58
  • Analyst Decision
  • OSPN Strong Buy
  • STOK Strong Buy
  • Analyst Count
  • OSPN 2
  • STOK 5
  • Target Price
  • OSPN $19.50
  • STOK $24.50
  • AVG Volume (30 Days)
  • OSPN 383.5K
  • STOK 534.4K
  • Earning Date
  • OSPN 07-31-2025
  • STOK 08-06-2025
  • Dividend Yield
  • OSPN 1.57%
  • STOK N/A
  • EPS Growth
  • OSPN N/A
  • STOK N/A
  • EPS
  • OSPN 1.48
  • STOK 0.88
  • Revenue
  • OSPN $241,702,000.00
  • STOK $190,908,000.00
  • Revenue This Year
  • OSPN $4.23
  • STOK $378.84
  • Revenue Next Year
  • OSPN $5.09
  • STOK N/A
  • P/E Ratio
  • OSPN $10.34
  • STOK $13.21
  • Revenue Growth
  • OSPN N/A
  • STOK 2333.81
  • 52 Week Low
  • OSPN $12.28
  • STOK $5.35
  • 52 Week High
  • OSPN $20.37
  • STOK $16.15
  • Technical
  • Relative Strength Index (RSI)
  • OSPN 40.20
  • STOK 67.25
  • Support Level
  • OSPN $15.61
  • STOK $11.43
  • Resistance Level
  • OSPN $15.90
  • STOK $12.25
  • Average True Range (ATR)
  • OSPN 0.44
  • STOK 0.51
  • MACD
  • OSPN -0.14
  • STOK 0.02
  • Stochastic Oscillator
  • OSPN 9.47
  • STOK 75.90

About OSPN OneSpan Inc.

OneSpan Inc is a provider of information technology security solutions for banking and financial services and application security markets. Its solutions secure and manage access to digital assets and protect online transactions, via mobile devices and in-person. Authentication and anti-fraud solutions are the organization's primary product offerings and include multifactor authentication and virtual private network access capabilities. The company derives revenues from hardware and license fees, maintenance and support fees, and subscription fees. A large majority of the firm's revenue is generated in Europe, the Middle East, and Africa, and the rest in the United States and Asia-Pacific region.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: